Granuloma transplantation: An approach to study Mycobacterium-host interactions

Frontiers in Microbiology

Volumn 2, Issue DEC, 2011, Pages

  Harding, Jeffrey S ^a   Schreiber, Heidi A ^a,b   Sandor, Matyas ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Granuloma, Transplantation, Mycobacteria, Host pathogen interactions

Indexed keywords

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 84860457208     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2011.00245     Document Type: Article

References (100)

1. Aaron, L., Saadoun, D., Calatroni, I., Launay, O., Memain, N., Vincent, V., Marchal, G., Dupont, B., Bouchaud, O., Valeyre, D., and Lortholary, O. (2004). Tuberculosis in HIV-infected patients: a comprehensive review. Clin. Microbiol. Infect. 10, 388-398.
2. Algood, H.M., Lin, P.L., and Flynn, J.L.(2005). Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas intuberculosis. Clin. Infect. Dis. 41(Suppl.3), S189-S193.
3. Armstrong, J. A., and Hart, P. D. (1975). Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle-bacilli. Reversal of usual nonfusion pattern and observations on bacterial survival. J. Exp. Med. 142, 1-16.
4. Barry, C. E. III., Boshoff, H. I., Dartois, V., Dick, T., Ehrt, S., Flynn, J., Schnappinger, D., Wilkinson, R. J., and Young, D. (2009). The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat. Rev. Microbiol. 7, 845-855.
5. Bean, A. G., Roach, D. R., Briscoe, H., France, M. P., Korner, H., Sedgwick, J. D., and Britton, W. J. (1999). Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J. Immunol. 162, 3504-3511.
6. Behr, M. A., Wilson, M. A., Gill, W. P., Salamon, H., Schoolnik, G. K., Rane, S., and Small, P. M. (1999). Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284, 1520-1523.
7. Bloch, H., Yamamura, Y., and Walter, A. (1960). Bacterial populations in experimental murine tuberculosis. II. Studies in vaccinated mice. J. Infect. Dis. 106, 223-229.
8. Blumberg, H. M., Leonard, M. K. Jr., and Jasmer, R. M. (2005). Update on the treatment of tuberculosis and latent tuberculosis infection. JAMA 293, 2776-2784.
9. Capuano, S. V. III., Croix, D. A., Pawar, S., Zinovik, A., Myers, A., Lin, P. L., Bissel, S., Fuhrman, C., Klein, E., and Flynn, J. L. (2003). Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various man-ifestations of human M. tuberculosis infection. Infect. Immun. 71, 5831-5844.
10. Cerda-Maira, F., and Darwin, K. H. (2009). The Mycobacterium tuberculosis proteasome: more than just a barrel-shaped protease. Microbes Infect. 11, 1150-1155.
11. Chambers, T. J., and Morson, B. C. (1979). The granuloma in Crohn's disease. Gut 20, 269-274.
12. Co, D. O., Hogan, L. H., Kim, S. I., and Sandor, M. (2004). Mycobac-terial granulomas: keys to a long-lasting host-pathogen relationship. Clin. Immunol. 113, 130-136.
13. Colditz, G. A., Berkey, C. S., Mosteller, F., Brewer, T. F., Wilson, M. E., Burdick, E., and Fineberg, H. V. (1995). The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 96, 29-35.
14. Colditz, G. A., Brewer, T. F., Berkey, C. S., Wilson, M. E., Burdick, E., Fineberg, H. V., and Mosteller, F. (1994). Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271, 698-702.
15. Connolly, L. E., Edelstein, P. H., and Ramakrishnan, L. (2007). Why is long-term therapy required to cure tuberculosis? PLoS Med. 4, e120. doi:10.1371/journal.pmed.0040120
16. Cooper, A. M., Dalton, D. K., Stewart, T. A., Griffin, J. P., Russell, D. G., and Orme, I. M. (1993). Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178, 2243-2247.
17. Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Rav-iglione, M. C., and Dye, C. (2003). The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 163, 1009-1021.
18. Cox, H., Hargreaves, S., and Ismailov, G. (2003). Effect of multidrug resistance on global tuberculosis control. Lancet 362, 1858-1859.
19. Cyster, J. G. (1999). Chemokines and cell migration in secondary lymphoid organs. Science 286, 2098-2102.
20. Darwin, K. H., Ehrt, S., Gutierrez-Ramos, J. C., Weich, N., and Nathan, C. F. (2003). The protea-some of Mycobacterium tuberculosis is required for resistance to nitric oxide. Science 302, 1963-1966.
21. Davis, J. M., and Ramakrishnan, L. (2008). "The very pulse of the machine": the tuberculous gran-uloma in motion. Immunity 28, 146-148.
22. Deretic, V., Singh, S., Master, S., Harris, J., Roberts, E., Kyei, G., Davis, A., De Haro, S., Naylor, J., Lee, H. H., and Vergne, I. (2006). Mycobacterium tuberculosis inhibition of phagolyso-some biogenesis and autophagy as a host defence mechanism. Cell. Microbiol. 8, 719-727.
23. Derrick, S. C., and Morris, S. L. (2007). The ESAT6 protein of Mycobacterium tuberculosis induces apopto-sis of macrophages by activating cas-pase expression. Cell. Microbiol. 9, 1547-1555.
24. Dheda, K., Booth, H., Huggett, J. F., Johnson, M. A., Zumla, A., and Rook, G. A. (2005). Lung remodeling in pulmonary tuberculosis. J. Infect. Dis. 192, 1201-1209.
25. Divangahi, M., Chen, M., Gan, H., Desjardins, D., Hickman, T. T., Lee, D. M., Fortune, S., Behar, S. M., and Remold, H. G. (2009). Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat. Immunol. 10, 899-906.
26. Fine, P. E. (1988). BCG vaccination against tuberculosis and leprosy. Br. Med. Bull. 44, 691-703.
27. Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A., and Bloom, B. R. (1993). An essential role for interferon-gamma in resistance to Mycobacterium-tuberculosis infection. J. Exp. Med. 178, 2249-2254.
28. Flynn, J. L., Goldstein, M. M., Chan, J., Triebold, K. J., Pfeffer, K., Lowenstein, C. J., Schreiber, R., Mak, T. W., and Bloom, B. R. (1995). Tumor-necrosis-factor-alpha is required in the protective immune-response against Mycobacterium-tuberculosis in mice. Immunity 2, 561-572.
29. Fortune, S. M., Solache, A., Jaeger, A., Hill, P. J., Belisle, J. T., Bloom, B. R., Rubin, E. J., and Ernst, J. D. (2004). Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms. J. Immunol. 172, 6272-6280.
30. Gan, H., Lee, J., Ren, F., Chen, M., Kornfeld, H., and Remold, H. G. (2008). Mycobacterium tuberculosis blocks crosslinking of annexin-1 and apoptotic envelope formation on infected macrophages to maintain virulence. Nat. Immunol. 9, 1189-1197.
31. Gandhi, N. R., Nunn, P., Dheda, K., Schaaf, H. S., Zignol, M., Van Soolingen, D., Jensen, P., and Bayona, J. (2010). Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 375, 1830-1843.
32. Gandotra, S., Lebron, M. B., and Ehrt, S. (2010). The Mycobacterium tuberculosis proteasome active site threonine is essential for persistence yet dispensable for replication and resistance to nitric oxide. PLoS Pathog. 6, e1001040. doi:10.1371/journal.ppat.1001040
33. Gardam, M. A., Keystone, E. C., Men-zies, R., Manners, S., Skamene, E., Long, R., and Vinh, D. C. (2003). Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect. Dis. 3, 148-155.
34. Gercken, J., Pryjma, J., Ernst, M., and Flad, H. D. (1994). Defective antigen presentation by Mycobac-terium tuberculosis-infected mono-cytes. Infect. Immun. 62, 3472-3478.
35. Gibbons, A. (2008). American Association of Physical Anthropologists meeting. Tuberculosis jumped from humans to cows, not vice versa. Science 320, 608.
36. Gomez, J. E., and McKinney, J. D. (2004). M. tuberculosis persistence, latency, and drug tolerance. Tu b e r -culosis (Edinb.) 84, 29-44.
37. Gordon, S. V., Brosch, R., Billault, A., Garnier, T., Eiglmeier, K., and Cole, S. T. (1999). Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol. Microbiol. 32, 643-655.
38. Guinn, K. M., Hickey, M. J., Mathur, S. K., Zakel, K. L., Grotzke, J. E., Lewin-sohn, D. M., Smith, S., and Sherman, D. R. (2004). Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis. Mol. Microbiol. 51, 359-370.
39. Gupta, U. D., and Katoch, V. M. (2005). Animal models of tuberculosis. Tuberculosis (Edinb.) 85, 277-293.
40. Hanekom, W. A., Mendillo, M., Manca, C., Haslett, P. A., Siddiqui, M. R., Barry, C. III., and Kaplan, G. (2003). Mycobacterium tuberculosis inhibits maturation of human monocyte-derived dendritic cells in vitro. J. Infect. Dis. 188, 257-266.
41. Hingley-Wilson, S. M., Samban-damurthy, V. K., and Jacobs, W. R. Jr. (2003). Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosis. Nat. Immunol. 4, 949-955.
42. Hsu, T., Hingley-Wilson, S. M., Chen, B., Chen, M., Dai, A. Z., Morin, P.M., Marks, C. B., Padiyar, J., Gould-ing, C., Gingery, M., Eisenberg, D., Russell, R. G., Derrick, S. C., Collins, F. M., Morris, S. L., King, C. H., and Jacobs, W. R. Jr. (2003). The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc. Natl. Acad. Sci. U.S.A. 100, 12420-12425.
43. Humphreys, I. R., Stewart, G. R., Turner, D. J., Patel, J., Karamanou, D., Snelgrove, R. J., and Young, D. B. (2006). A role for dendritic cells in the dissemination of mycobac-terial infection. Microbes Infect. 8, 1339-1346.
44. Iseman, M. D., and Sbarbaro, J. A. (1992). The increasing prevalence of resistance to antituberculosis chemotherapeutic agents: implications for global tuberculosis control. Curr. Clin. Top. Infect. Dis. 12, 188-207.
45. Kaneshima, H., Shih, C. C., Namikawa, R., Rabin, L., Outzen, H., Machado, S. G., and Mccune, J. M. (1991). Human immunodeficiency virus infection of human lymph nodes in the SCID-hu mouse. Proc. Natl. Acad. Sci. U.S.A. 88, 4523-4527.
46. Kaufmann, S. H. (2002). Protection against tuberculosis: cytokines, T cells, and macrophages. Ann. Rheum. Dis. 61(SUPPL. 2), ii54-ii58.
47. Kaufmann, S. H. (2003). Immune response to tuberculosis: experimental animal models. Tuberculosis (Edinb.) 83, 107-111.
48. Keane, J. (2005). TNF-blocking agents and tuberculosis: new drugs illuminate an old topic. Rheumatology (Oxford) 44, 714-720.
49. Lerche, N. W., Yee, J. L., Capuano, S. V., and Flynn, J. L. (2008). New approaches to tuberculosis surveillance in nonhuman primates. ILAR J. 49, 170-178.
50. Lewis, K. N., Liao, R., Guinn, K. M., Hickey, M. J., Smith, S., Behr, M. A., and Sherman, D.R. (2003). Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guerin attenuation. J. Infect. Dis. 187, 117-123.
51. Lin, G., Li, D., De Carvalho, L. P., Deng, H., Tao, H., Vogt, G., Wu, K., Schneider, J., Chidawanyika, T., Warren, J. D., Li, H., and Nathan, C. (2009a). Inhibitors selective for mycobacterial versus human protea-somes. Nature 461, 621-626.
52. Lin, P. L., Rodgers, M., Smith, L., Bigbee, M., Myers, A., Bigbee, C., Chiosea, I., Capuano, S. V., Fuhrman, C., Klein, E., and Flynn, J. L. (2009b). Quantitative comparison of active and latent tuberculosis in the cynomol-gus macaque model. Infect. Immun. 77, 4631-4642.
53. Lin, P. L., and Flynn, J. L. (2010). Understanding latent tuberculosis: a moving target. J. Immunol. 185, 15-22.
54. Manabe, Y. C., and Bishai, W. R. (2000). Latent Mycobacterium tuberculosis-persistence, patience, and winning by waiting. Nat. Med. 6, 1327-1329.
55. Martin-Fontecha, A., Sebastiani, S., Hopken, U. E., Uguccioni, M., Lipp, M., Lanzavecchia, A., and Sallusto, F. (2003). Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 198, 615-621.
56. McCune, J. M., Namikawa, R., Kaneshima, H., Shultz, L. D., Lieberman, M., and Weissman, I. L. (1988). The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241, 1632-1639.
57. McCune, R. M. Jr., Mcdermott, W., and Tompsett, R. (1956). The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug. J. Exp. Med. 104, 763-802.
58. McCune, R. M. Jr., and Tompsett, R. (1956). Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy. J. Exp. Med. 104, 737-762.
59. McCune, R. M., Feldmann, F. M., Lambert, H. P., and Mcdermott, W. (1966). Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues. J. Exp. Med. 123, 445-468.
60. McKinney, J. D., Honer Zu Bentrup, K., Munoz-Elias, E. J., Miczak, A., Chen, B., Chan, W. T., Swenson, D., Sacchettini, J. C., Jacobs, W. R. Jr., and Russell, D. G. (2000). Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isoci-trate lyase. Nature 406, 735-738.
61. McMurray, D. N., Collins, F. M., Dannenberg, A. M. Jr., and Smith, D. W. (1996). Pathogenesis of experimental tuberculosis in animal models. Curr. Top. Microbiol. Immunol. 215, 157-179.
62. Mostowy, S., and Behr, M. A. (2005). The origin and evolution of Mycobacterium tuberculosis. Clin. Chest Med. 26, 207-216, v-vi.Narayanan
63. Narayanan R.B. (1988). Immunopathology of leprosy granulomas - current status: a review. Lepr. Rev. 59, 75-82.
64. Orme, I. (1995). Mechanisms underlying the increased susceptibility of aged mice to tuberculosis. Nutr. Rev. 53, S35-S38; discussion S38-S40.
65. Orme, I. M. (1987). The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J. Immunol. 138, 293-298.
66. Pandey, A. K., and Sassetti, C. M. (2008). Mycobacterial persistence requires the utilization of host cholesterol. Proc. Natl. Acad. Sci. U.S.A. 105, 4376-4380.
67. Paramasivan, C. N., Sulochana, S., Kubendiran, G., Venkatesan, P., and Mitchison, D. A. (2005). Bactericidal action of gatifloxacin, rifampin, and isoniazid on logarithmic-and stationary-phase cultures of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 49, 627-631.
68. Philipp, W. J., Nair, S., Guglielmi, G., Lagranderie, M., Gicquel, B., and Cole, S. T. (1996). Physical mapping of Mycobacterium bovis BCG pasteur reveals differences from the genome map of Mycobacterium tuberculosis H37Rv and from M. bovis. Microbiology 142(Pt 11), 3135-3145.
69. Porcelli, S. A., and Jacobs, W. R. Jr. (2008). Tuberculosis: unsealing the apoptotic envelope. Nat. Immunol. 9, 1101-1102.
70. Randolph, G. J. (2001). Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators. Semin. Immunol. 13, 267-274.
71. Reljic, R., Di Sano, C., Crawford, C., Dieli, F., Challacombe, S., and Ivanyi, J. (2005). Time course of mycobacte-rial infection of dendritic cells in the lungs of intranasally infected mice. Tuberculosis (Edinb.) 85, 81-88.
72. Roach, D. R., Briscoe, H., Baum-gart, K., Rathjen, D. A., and Brit-ton, W. J. (1999). Tumor necrosis factor (TNF) and a TNF-mimetic peptide modulate the granuloma-tous response to Mycobacterium bovis BCG infection in vivo. Infect. Immun. 67, 5473-5476.
73. Russell, D. G. (2007). Who puts the tubercle in tuberculosis? Nat. Rev. Microbiol. 5, 39-47.
74. Russell, D. G., Cardona, P. J., Kim, M. J., Allain, S., and Altare, F. (2009). Foamy macrophages and the progression of the human tuberculosis granuloma. Nat. Immunol. 10, 943-948.
75. Saunders, B. M., and Cooper, A. M. (2000). Restraining mycobacteria:role of granulomas in mycobacter-ial infections. Immunol. Cell Biol. 78, 334-341.
76. Scanga, C. A., Mohan, V. P., Joseph, H., Yu, K., Chan, J., and Flynn, J. L. (1999). Reactivation of latent tuberculosis: variations on the Cornell murine model. Infect. Immun. 67, 4531-4538.
77. Schreiber, H. A., Harding, J. S., Altamirano, C. J., Hunt, O., Hulseberg, P. D., Fabry, Z., and Sandor, M. (2011a). Continuous repopulation of lymphocyte subsets in transplanted mycobacterial granulomas. Eur. J. Microbiol. Immunol. (Bp) 1, 59-69.
78. Schreiber, H. A., Harding, J. S., Hunt, O., Altamirano, C. J., Hulseberg, P. D., Stewart, D., Fabry, Z., and Sandor, M. (2011b). Inflammatory dendritic cells migrate in and out of transplanted chronic mycobac-terial granulomas in mice. J. Clin. Invest. 121, 3902-3913.
79. Schreiber, H. A., Hulseberg, P. D., Lee, J., Prechl, J., Barta, P., Szlavik, N., Harding, J. S., Fabry, Z., and San-dor, M. (2010). Dendritic cells in chronic mycobacterial granulomas restrict local anti-bacterial T cell response in a murine model. PLoS ONE 5, e11453. doi:10.1371/jour-nal.pone.0011453
80. Schreiber, H. A., and Sandor, M. (2010). The role of dendritic cells in Mycobacterium-induced granulo-mas. Immunol. Lett. 130, 26-31.
81. Schuck, S. D., Mueller, H., Kunitz, F., Neher, A., Hoffmann, H., Franken, K. L., Repsilber, D., Ottenhoff, T. H., Kaufmann, S. H., and Jacobsen, M. (2009). Identification of T-cell antigens specific for latent Mycobac-terium tuberculosis infection. PLoS ONE 4, e5590. doi:10.1371/jour-nal.pone.0005590
82. Sever, J. L., and Youmans, G. P. (1957). Enumeration of viable tubercle bacilli from the organs of nonimmu-nized and immunized mice. Am. Rev. Tu b e r c. 76, 616-635.
83. Smith, D., Wiegeshaus, E., and Balasub-ramanian, V. (2000). Animal models for experimental tuberculosis. Clin. Infect. Dis. 31(Suppl. 3), S68-S70.
84. Smith, J., Manoranjan, J., Pan, M., Bohsali, A., Xu, J., Liu, J., Mcdonald, K. L., Szyk, A., Laronde-Leblanc, N., and Gao, L. Y. (2008). Evidence for pore formation in host cell membranes by ESX-1-secreted ESAT-6 and its role in Mycobacterium mar-inum escape from the vacuole. Infect. Immun. 76, 5478-5487.
85. Smith, N. H., Hewinson, R. G., Kre-mer, K., Brosch, R., and Gordon, S. V. (2009). Myths and misconceptions: the origin and evolutionof Mycobacterium tuberculosis. Nat. Rev. Microbiol. 7, 537-544.
86. Sreevatsan, S., Pan, X., Stockbauer, K. E., Connell, N. D., Kreiswirth, B. N., Whittam, T. S., and Musser, J. M. (1997). Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionar-ily recent global dissemination. Proc. Natl. Acad. Sci. U.S.A. 94, 9869-9874.
87. Stenger, S., and Modlin, R. L. (1999). T cell mediated immunity to Mycobac-terium tuberculosis. Curr. Opin. Microbiol. 2, 89-93.
88. Stenger, S., Niazi, K. R., and Modlin, R. L. (1998). Down-regulation of CD1 on antigen-presenting cells by infection with Mycobacterium tuberculosis. J. Immunol. 161, 3582-3588.
89. Sturgill-Koszycki, S., Schlesinger, P. H., Chakraborty, P., Haddix, P. L., Collins, H. L., Fok, A. K., Allen, R. D., Gluck, S. L., Heuser, J., and Russell, D. G. (1994). Lack of acidification in Mycobacterium phago-somes produced by exclusion of the vesicular proton-ATPase. Science 263, 678-681.
90. Tsai, M. C., Chakravarty, S., Zhu, G., Xu, J., Tanaka, K., Koch, C., Tufariello, J., Flynn, J., and Chan, J. (2006). Characterization of the tuberculous gran-uloma in murine and human lungs: cellular composition and relative tissue oxygen tension. Cell. Microbiol. 8, 218-232.
91. Via, L. E., Deretic, D., Ulmer, R. J., Hibler, N. S., Huber, L. A., and Deretic, V. (1997). Arrest of mycobacterial phagosome maturation is caused by a block in vesicle fusion between stages controlled by rab5 and rab7. J. Biol. Chem. 272, 13326-13331.
92. Volkman, H. E., Clay, H., Beery, D., Chang, J. C., Sherman, D. R., and Ramakrishnan, L. (2004). Tuberculous granu-loma formation is enhanced by a Mycobacterium virulence determinant. PLoS Biol. 2, e367. doi:10.1371/journal.pbio.0020367
93. Wallis, R. S., Broder, M. S., Wong, J. Y., Hanson, M. E., and Been-houwer, D. O. (2004). Granulo-matous infectious diseases associated with tumor necrosis factor antagonists. Clin. Infect. Dis. 38, 1261-1265.
94. Wallis, R. S., Patil, S., Cheon, S. H., Edmonds, K., Phillips, M., Perkins, M. D., Joloba, M., Namale, A., Johnson, J. L., Teixeira, L., Dietze, R., Sid-diqi, S., Mugerwa, R. D., Eisenach, K., and Ellner, J. J. (1999). Drug tolerance in Mycobacterium tuberculosis.Antimicrob. Agents Chemother. 43, 2600-2606.
95. Wheat, J., Sarosi, G., Mckinsey, D., Hamill, R., Bradsher, R., Johnson, P., Loyd, J., and Kauffman, C. (2000). Practice guidelines for the management of patients with histoplasmosis. Infectious diseases society of America. Clin. Infect. Dis. 30, 688-695.
96. WHO Global Tuberculosis Control Report 2010.Summary.(2010). Cent. Eur. J. Public Health 18, 237.
97. Wirth, T., Hildebrand, F., Allix-Beguec, C., Wolbeling, F., Kubica, T., Kremer, K., Van Soolingen, D., Rusch-Gerdes, S., Locht, C., Brisse, S., Meyer, A., Supply, P., and Niemann, S. (2008). Origin, spread and demography of the Mycobacterium tuberculosis complex. PLoS Pathog. 4, e1000160. doi:10.1371/journal.ppat.1000160
98. Wolfe, F., Michaud, K., Anderson, J., and Urbansky, K. (2004). Tuberculosis infection in patients with rheumatoid arthritis and the effect of inflix-imab therapy. Arthritis Rheum. 50, 372-379.
99. Xu, S., Cooper, A., Sturgill-Koszycki, S., Van Heyningen, T., Chatterjee, D., Orme, I., Allen, P., and Russell, D. G. (1994). Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium-infected macrophages. J. Immunol. 153, 2568-2578.
100. Zhang Y. The magic bullets and tuberculosis drug targets. Annu. Rev. Pharmacol. Toxicol. 2005. 45: 529-564.